Benign Prostatic Hypertrophy
25
0
1
19
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.0%
3 terminated out of 25 trials
86.4%
-0.1% vs benchmark
28%
7 trials in Phase 3/4
26%
5 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (25)
Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter
Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology
Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)
Wolf 24 F vs. Storz 28 F Laser Sheath Size for HoLEP
Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial
Transurethral Vapor Enucleation Resection of the Prostate (TVERP), Bipolar TURis and HoLEP
The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
Feasibility Study of Photovaporisation of Prostate With a Limitated Length of Catheterization of 3 Hours
Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH)
Comparison of Different Energy Sources During TUR-P
Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study
Safety and Efficacy of OCL 503 in Prostate Artery Embolization
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate
Prostate Cancer Antigen 3 (PCA-3) Gene Project
The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly
Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia
Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)